Clinical Trials Logo

Clinical Trial Summary

A: Early predictors of hepatic injury after suicide attempt with acetaminophen:

To explore the following in a pediatric population with acetaminophen overdose due to suicide attempt: 1) the prevalence of episodes of pre- and in-hospital vomiting and the relationship between the total number of vomiting episodes and hepatic injury, 2) the relevance of the early initiation of N-acetylcysteine (NAC) treatment to hepatic injury, and 3) the presence/absence of illness prior to the suicide attempt and hepatic injury.

B: Characteristics, social behaviour, trends and risk factors:

1. To explore the relationship between children admitted to a paediatric department as a result of suicide attempts with acetaminophen and their parents and friends. 2. To determine the extent to which the children had attempted to speak to their parents or other adults about their problems before their suicide attempts. 3. To determine the prevalence of self-mutilation among children with suicidal behaviour. 4. To examine the reasons for these suicide attempts.

C: Establishment of the expression of cytochrome P450 in a pediatric including the age-adjusted activities.

Urine samples will be analyzed using an HPLC tandem mass spectrometric method, which we have already established in our lab.

There will be categorized three groups for comparison:

1. An age-appropriate background population (approximately 200 patients)

2. Paediatric patients that have been admitted to Rigshospitalet, due to severe hepatic injury (approximately 50 patients)

3. Other pediatric patients admitted to their local hospital because of acetaminophen poisoning (approximately 200 patients) A control urine sample will be analyzed three months after the suicide attempt.


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only


Related Conditions & MeSH terms


NCT number NCT01981213
Study type Observational [Patient Registry]
Source Hillerod Hospital, Denmark
Contact Rikke L. Hedeland, MD
Phone 004548294356
Email rikke.hedeland@regionh.dk
Status Recruiting
Phase N/A
Start date January 2005
Completion date August 2015

See also
  Status Clinical Trial Phase
Terminated NCT01325584 - Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury Phase 2
Completed NCT05028595 - Evaluation of Hepatic Affection in Hemodialysis Patients With Iron Overload in Assiut University Hospital
Completed NCT06249646 - Contained Hepatic Vascular Injuries Following Liver Trauma